Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Anthropic's IPO Could Come Within Weeks. Amazon Already Owns a Piece of It.fool.com
The e-commerce giant already carries its stake at around $239 billion. What changes when the Claude maker's stock trades?
Via The Motley Fool · November 7, 2026
Decoding Healthcare ETFs: Different Sectors, Different Strategiesfool.com
RSPH offers broader sector diversification with lower volatility, while XBI delivers higher short-term gains but with steeper drawdowns.
Via The Motley Fool · November 7, 2026
SCHD Just Hit a Record High Following Midterm Election Results. I'd Still Rather Buy This Dividend King for Passive Income.fool.com
Investors are pouring into dividend-paying stocks and ETFs as Democrats gain control of Congress.
Via The Motley Fool · November 7, 2026
Datadog vs. Docusign: Which Technology Stock Is a Better Buy for 2027?fool.com
Datadog's revenue is growing roughly three times faster than Docusign's, but the valuation gap between them is just as striking.
Via The Motley Fool · November 7, 2026
AMD Stock Popped After Earnings, Then Gave It All Back. Is It a Buy Now?fool.com
AMD's results were good, but the overall picture of the stock isn't as great.
Via The Motley Fool · November 7, 2026
Here's the Average Social Security Benefit at Age 62fool.com
Claiming at 62 means accepting a permanent reduction in monthly income, but it unlocks years of immediate cash flow.
Via The Motley Fool · November 7, 2026
Why Marvell Technology Stock Plunged 28.1% This Weekfool.com
Investors don't see Marvell's new acquisition as being so marvelous.
Via The Motley Fool · November 7, 2026
Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?marketbeat.com
Astera Labs posted Q3 revenue up 153.6% and strong EPS growth, beating estimates, while analysts trimmed price targets but kept bullish ratings amid the stock's recent pullback.
Via MarketBeat · November 7, 2026
What James Hardie Industries (JHX) Said on Its Q2 Earnings Callmarketbeat.com
James Hardie Industries (NYSE:JHX) reported higher sales and earnings for its fiscal second quarter and raised its free cash flow target, even as management lowered its outlook for the housing market. Net sales from continuing operations rose 24% from a year earlier to $1.43 billion. Adjusted EBITD
Via MarketBeat · November 7, 2026
McDonald's Q3 Earnings Call Highlightsmarketbeat.com
McDonald's (NYSE:MCD) said U.S. comparable sales turned positive in September after declines earlier in the third quarter, as the company restored digital promotions and shifted marketing toward established value offerings. The chain is now testing additional low-priced bundles ahead of a planned na
Via MarketBeat · November 7, 2026
MBIA Q3 Earnings Call Highlightsmarketbeat.com
MBIA (NYSE:MBI) reported a wider third-quarter net loss as a smaller benefit from insurance loss reserves weighed on results, while executives said resolving the company’s exposure to Puerto Rico’s electric utility remains their operational priority. The financial guarantor posted a consolidated ne
Via MarketBeat · November 7, 2026
What JELD-WEN (JELD) Said on Its Q3 Earnings Callmarketbeat.com
JELD-WEN (NYSE:JELD) reported higher adjusted earnings for the third quarter of 2026, helped by tariff refunds and cost savings, while warning that demand for windows and doors was weaker than expected. The company maintained its full-year revenue and adjusted EBITDA guidance despite lowering its m
Via MarketBeat · November 7, 2026
Nextdoor Q3 Earnings Call Highlightsmarketbeat.com
Nextdoor (NYSE:NXDR) reported third-quarter revenue and adjusted earnings above its guidance as weekly active users grew for a third consecutive quarter, helped by product changes and the return of previously inactive users. Revenue rose 14% year over year to $78.8 million, exceeding the company’s
Via MarketBeat · November 7, 2026
What Moelis & Company (MC) Said on Its Q3 Earnings Callmarketbeat.com
Moelis & Company (NYSE:MC) reported third-quarter 2026 revenue of $426 million, up 13% from a year earlier, as growth in mergers and acquisitions and capital structure advisory offset a softer quarter in capital markets. Revenue for the first nine months rose 10% to a record $1.15 billion, CEO
Via MarketBeat · November 7, 2026
What Mativ (MATV) Said on Its Q3 Earnings Callmarketbeat.com
Mativ (NYSE:MATV) reported lower third-quarter sales and adjusted earnings after a tornado disrupted its paper and packaging distribution network, offsetting growth in its advanced materials business. Executives said they expect sales volumes to grow in both operating segments in the fourth quarter,
Via MarketBeat · November 7, 2026
MasterBrand Q3 Earnings Call Highlightsmarketbeat.com
MasterBrand (NYSE:MBC) expects weaker cabinet demand and rising costs to pressure fourth-quarter earnings, as the company integrates its merger with American Woodmark and pushes back its debt-reduction target by a year. The cabinet maker reported third-quarter net sales of $1.04 billion in its firs
Via MarketBeat · November 7, 2026
What Main Street Capital (MAIN) Said on Its Q3 Earnings Callmarketbeat.com
Main Street Capital (NYSE:MAIN) reported a record net asset value per share for the third quarter of 2026, as appreciation in its investment portfolio helped offset slower investment activity and lower distributable income compared with earlier periods. The company’s net asset value rose to $34.22
Via MarketBeat · November 7, 2026
Madison Air Solutions Q3 Earnings Call Highlightsmarketbeat.com
Madison Air Solutions (NYSE:MAIR) raised its full-year outlook after third-quarter sales rose 25%, with demand for data center cooling and other commercial products contributing to a record backlog. The company reported net sales of $1.127 billion and adjusted EBITDA of approximately $299 million,
Via MarketBeat · November 7, 2026
Here's How These 6 Big Bank Stocks Make Their Moneyfool.com
From card fees and wealth management to equities trading, here's where each of the six biggest banks made its money last quarter.
Via The Motley Fool · November 7, 2026
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?fool.com
Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.
Via The Motley Fool · November 7, 2026
3 Artificial Intelligence (AI) Stocks I’d Buy Without Hesitation in a Market Crashfool.com
These companies have promising prospects. They would be even more attractive on the dip.
Via The Motley Fool · November 7, 2026
Not Nvidia. Not Micron. After the Chip Sell-Off, I'd Buy This AI Stock and Hold It Forever.fool.com
The market is shifting away from chip stocks, but that could create some great opportunities for investors.
Via The Motley Fool · November 7, 2026
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?fool.com
PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.
Via The Motley Fool · November 7, 2026
Lyntris: 3 Key Takeaways for Long-Term Investorsfool.com
Early program design embeds Lyntris's proprietary tech, so repeat production orders could lift margins as the business scales over time.
Via The Motley Fool · November 7, 2026
Booking vs. DoorDash: Does Going Out or Staying In Make One Stock a Better Buy for 2027?fool.com
Booking's cash machine versus DoorDash's rapid share gains set up a clear trade-off for 2027, with valuation tilting the scales in an unexpected direction.
Via The Motley Fool · November 7, 2026